Literature DB >> 31867817

Transient atypical monocytosis after α/β T-cell-depleted haploidentical hematopoietic stem cell transplantation.

Angela Liou1, John Van Arnam2, Vinodh Pillai2, Alix E Seif1,3, Sarah K Tasian1,3, Charles A Phillips1,3,4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31867817      PMCID： PMC7721203          DOI： 10.1002/pbc.28139

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  10 in total

Review 1.  Biological and therapeutic aspects of infant leukemia.

Authors:  A Biondi; G Cimino; R Pieters; C H Pui
Journal:  Blood       Date:  2000-07-01       Impact factor: 22.113

2.  Lineage Switch in MLL-Rearranged Infant Leukemia Following CD19-Directed Therapy.

Authors:  Ahmad Rayes; Richard L McMasters; Maureen M O'Brien
Journal:  Pediatr Blood Cancer       Date:  2016-02-23       Impact factor: 3.167

3.  Monocytes and gammadelta T cells: close encounters in microbial infection.

Authors:  Matthias Eberl; Bernhard Moser
Journal:  Trends Immunol       Date:  2009-10-21       Impact factor: 16.687

4.  Lineage switch from B acute lymphoblastic leukemia to acute monocytic leukemia with persistent t(4;11)(q21;q23) and cytogenetic evolution under CD19-targeted therapy.

Authors:  Estelle Balducci; Vanessa Nivaggioni; John Boudjarane; Lakhdar Bouriche; Ilhem Rahal; Denis Bernot; Emilie Alazard; Nicolas Duployez; Nathalie Grardel; Isabelle Arnoux; Marina Lafage-Pochitaloff; Gérard Michel; Bertrand Nadel; Marie Loosveld
Journal:  Ann Hematol       Date:  2017-06-20       Impact factor: 3.673

5.  Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia (MLL)-rearranged acute lymphoblastic leukemia: results from the Interfant-99 Study.

Authors:  Georg Mann; Andishe Attarbaschi; Martin Schrappe; Paola De Lorenzo; Christina Peters; Ian Hann; Giulio De Rossi; Maria Felice; Birgitte Lausen; Thierry Leblanc; Tomasz Szczepanski; Alina Ferster; Gritta Janka-Schaub; Jeffrey Rubnitz; Lewis B Silverman; Jan Stary; Myriam Campbell; Chi Kong Li; Ram Suppiah; Andrea Biondi; Ajay Vora; Maria Grazia Valsecchi; Rob Pieters
Journal:  Blood       Date:  2010-06-30       Impact factor: 22.113

6.  Outcome of children with acute leukemia given HLA-haploidentical HSCT after αβ T-cell and B-cell depletion.

Authors:  Franco Locatelli; Pietro Merli; Daria Pagliara; Giuseppina Li Pira; Michela Falco; Daniela Pende; Roberto Rondelli; Barbarella Lucarelli; Letizia Pomponia Brescia; Riccardo Masetti; Giuseppe Maria Milano; Valentina Bertaina; Mattia Algeri; Rita Maria Pinto; Luisa Strocchio; Raffaella Meazza; Lavinia Grapulin; Rupert Handgretinger; Alessandro Moretta; Alice Bertaina; Lorenzo Moretta
Journal:  Blood       Date:  2017-06-06       Impact factor: 22.113

7.  Second Allogeneic Stem Cell Transplantation for Acute Leukemia Using a Chemotherapy-Only Cytoreduction with Clofarabine, Melphalan, and Thiotepa.

Authors:  Barbara Spitzer; Miguel-Angel Perales; Nancy A Kernan; Susan E Prockop; Emily C Zabor; Nicholas Webb; Hugo Castro-Malaspina; Esperanza B Papadopoulos; James W Young; Andromachi Scaradavou; Rachel Kobos; Sergio A Giralt; Richard J O'Reilly; Farid Boulad
Journal:  Biol Blood Marrow Transplant       Date:  2016-05-13       Impact factor: 5.742

8.  Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocol.

Authors:  Marieke H van der Linden; Maria Grazia Valsecchi; Paola De Lorenzo; Anja Möricke; Gritta Janka; Thierry M Leblanc; Maria Felice; Andrea Biondi; Myriam Campbell; Ian Hann; Jeffrey E Rubnitz; Jan Stary; Tomasz Szczepanski; Ajay Vora; Alina Ferster; Liisa Hovi; Lewis B Silverman; Rob Pieters
Journal:  Blood       Date:  2009-08-05       Impact factor: 22.113

9.  A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial.

Authors:  Rob Pieters; Martin Schrappe; Paola De Lorenzo; Ian Hann; Giulio De Rossi; Maria Felice; Liisa Hovi; Thierry LeBlanc; Tomasz Szczepanski; Alice Ferster; Gritta Janka; Jeffrey Rubnitz; Lewis Silverman; Jan Stary; Myriam Campbell; Chi-Kong Li; Georg Mann; Ram Suppiah; Andrea Biondi; Ajay Vora; Maria Grazia Valsecchi
Journal:  Lancet       Date:  2007-07-21       Impact factor: 79.321

10.  CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity.

Authors:  Elad Jacoby; Sang M Nguyen; Thomas J Fountaine; Kathryn Welp; Berkley Gryder; Haiying Qin; Yinmeng Yang; Christopher D Chien; Alix E Seif; Haiyan Lei; Young K Song; Javed Khan; Daniel W Lee; Crystal L Mackall; Rebecca A Gardner; Michael C Jensen; Jack F Shern; Terry J Fry
Journal:  Nat Commun       Date:  2016-07-27       Impact factor: 14.919
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.